PPT-Non-vitamin K antagonist oral anticoagulants
Author : tawny-fly | Published Date : 2019-03-15
NOACs YOUR FACILITY Presenter Month YYYY September 2016 Version 2 This session will provide an Introduction to highrisk medicines Overview of NOACs also known
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Non-vitamin K antagonist oral anticoagul..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Non-vitamin K antagonist oral anticoagulants: Transcript
NOACs YOUR FACILITY Presenter Month YYYY September 2016 Version 2 This session will provide an Introduction to highrisk medicines Overview of NOACs also known as DOACs Direct Oral Anticoagulant . Protagonist. The main character of the story or drama, the hero, who is faced with an opposing force to overcome in order to achieve a goal. Give some examples of a protagonist. Nemo. -. Finding . Nemo. This will help you answer 1 and 2 in your packet. Protagonist. Main character who comes into conflict with an opposing major character or force. In fiction, the story of the protagonist can be told from the perspective of a different character (who may also but not necessarily, be the . Research Advisory Committee. David . Kratville. Senior Environmental Scientist. CDFA – Integrated Pest Control Branch. Vertebrate Pests. Purpose of this training. Overview of rodenticides. History of VPCRAC. preservativemultivitaminsupplementpresented F A C A F L F F F omposit imited a F Solubl Solubl / i & Vitamin A Vitamin D Vitamin B Vitamin B Vitamin B Vitamin B Vitamin C Vitamin Biotin Pantothe Vitam Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. Adam . Bisaga. M.D.. Professor of Psychiatry. Columbia University Medical Center. Workshop Outline. Naltrexone-assisted treatment of OUD. Section 1: . Introduction to antagonist-based treatment of OUD . Vitamin C is a water soluble vitamin that is commonly found in fruits and vegetables.. Where Does It Come From?. Kiwi. Oranges. Sweet potatoes. Lemons. Tomatoes. Strawberries. Turnip Greens. Broccoli. Classify adrenergic antagonists . Describe actions, therapeutic uses & adverse effects of adrenergic antagonist.. b. Discuss the role of autonomic drugs in central nervous system disorders. c. Enlist drugs used in glaucoma. or . vitamin B-12. , also called . cobalamin. , is a water soluble . vitamin. with a key role in the normal functioning of the . brain. and . nervous system. , and for the formation of . blood. . It is one of the eight . Anna Maria Nardiello. 1,. *, Lucia Sessa. 1,2. , Jacopo Santoro. 1. and Stefano Piotto. 1,2. 1. . Department of Pharmacy, University of Salerno, . Fisciano. , 84084, Italy. 2. . Research. Centre for . , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. ?. That . major bleeding . occurs in about . 6.5% of patients on anticoagulants.. . That’s. . 1 patient in 15. . and commonly, GI Bleeding.. That . 1% . is . fatal bleeding . such as intracranial hemorrhage.. existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo MD., DA., DNB, Dip. Diab., PhD (physiology). Dip. Software based statistics- . IDRA, CUGRA . What are they ? . Minor changes in the structure of an opioid agonist. . convert the drug into an opioid antagonist at one or more of the opioid receptor sites .
Download Document
Here is the link to download the presentation.
"Non-vitamin K antagonist oral anticoagulants"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents